Beacon Pointe Advisors, LLC Biogen Inc. Transaction History

Beacon Pointe Advisors, LLC

$8.55 Billion
Q3 2024

A detailed history of Beacon Pointe Advisors, LLC transactions in Biogen Inc. stock. As of the latest transaction made, Beacon Pointe Advisors, LLC holds 1,388 shares of BIIB stock, worth $208,880. This represents 0.0% of its overall portfolio holdings.

Number of Shares

1,388

Previous 1,673 17.04%

Holding current value

$208,880

Previous $387,000 30.49%

% of portfolio

0.0%

Previous 0.0%

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	SELL	$189.07 - $236.8 $53,884 - $67,488	-285 Reduced 17.04%	1,388 $269,000
Q2 2024 Aug 12, 2024	SELL	$190.52 - $236.72 $496,495 - $616,892	-2,606 Reduced 60.9%	1,673 $387,000
Q1 2024 May 14, 2024	SELL	$212.02 - $267.71 $55,761 - $70,407	-263 Reduced 5.79%	4,279 $922,000
Q4 2023 Feb 08, 2024	SELL	$222.59 - $267.94 $3.03 Million - $3.65 Million	-13,614 Reduced 74.98%	4,542 $1.18 Million
Q3 2023 Nov 14, 2023	BUY	$253.3 - $285.89 $4.26 Million - $4.8 Million	16,806 Added 1244.89%	18,156 $4.67 Million
Q2 2023 Aug 11, 2023	BUY	$275.25 - $318.06 $22,570 - $26,080	82 Added 6.47%	1,350 $384,000
Q1 2023 May 12, 2023	SELL	$256.56 - $292.34 $69,527 - $79,224	-271 Reduced 17.61%	1,268 $352,000
Q4 2022 Feb 14, 2023	BUY	$252.44 - $306.72 $68,411 - $83,121	271 Added 21.37%	1,539 $426,000
Q3 2022 Nov 09, 2022	BUY	$194.69 - $268.46 $2,336 - $3,221	12 Added 0.96%	1,268 $341,000
Q2 2022 Aug 11, 2022	SELL	$187.54 - $223.02 $2.29 Million - $2.72 Million	-12,207 Reduced 90.67%	1,256 $255,000
Q1 2022 May 17, 2022	BUY	$193.77 - $244.14 $2.01 Million - $2.53 Million	10,369 Added 335.13%	13,463 $2.84 Million
Q4 2021 Feb 14, 2022	BUY	$223.92 - $287.77 $224,591 - $288,633	1,003 Added 47.97%	3,094 $742,000
Q3 2021 Nov 15, 2021	SELL	$282.99 - $369.05 $185,358 - $241,727	-655 Reduced 23.85%	2,091 $592,000
Q2 2021 Aug 17, 2021	BUY	$259.0 - $414.71 $457,394 - $732,377	1,766 Added 180.2%	2,746 $951,000
Q1 2021 May 18, 2021	BUY	$242.95 - $284.63 $238,091 - $278,937	980 New	980 $271,000
Q2 2019 Aug 14, 2019	SELL	$219.29 - $241.72 $1.64 Million - $1.81 Million	-7,472 Closed	0 $0
Q1 2019 May 14, 2019	BUY	$216.71 - $338.96 $1.62 Million - $2.53 Million	7,472 New	7,472 $1.77 Million

Others Institutions Holding BIIB

# of Institutions

1,038

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $21.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Beacon Pointe Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Beacon Pointe Advisors, LLC with notifications on news.

Account

Beacon Pointe Advisors, LLC Biogen Inc. Transaction History